News|Articles|December 2, 2004
- Pharmaceutical Technology-12-02-2004
- Volume 28
- Issue 11
Robust CRO Market Is Driving New Merger and Acquisition Activity
Author(s)Jim Miller
The blockage in the new product pipeline may be breaking. CROs report increased demand for late-stage development services in their latest round of earnings reports.
Advertisement
Articles in this issue
about 21 years ago
In the Spotlight-December 2004about 21 years ago
Safety Problems Roil Pharma and FDAabout 21 years ago
December 2004about 21 years ago
The Seventh Annual International Employment Surveyabout 21 years ago
Pharmaco-FakeryNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
Women in STEM: Early Phase Drug Development
3
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
4
PharmTech Weekly Roundup - February 6, 2026
5